Research and Markets: Nigeria Pharmaceuticals and Healthcare Report Q3 2012
DUBLIN–()–Research and Markets (http://www.researchandmarkets.com/research/zmwjdc/nigeria_pharmaceut)
has announced a serve of a “Nigeria
Pharmaceuticals and Healthcare Report Q3 2012″ news to their
offering.
“Nigeria
Pharmaceuticals and Healthcare Report Q3 2012”
Business Monitor International’s Nigeria Pharmaceuticals and Healthcare
Report provides attention professionals and strategists, corporate
analysts, curative associations, supervision departments and
regulatory bodies with eccentric forecasts and competitive
comprehension on Nigeria’s pharmaceuticals and medical industry.
BMI View: The Nigerian curative marketplace continues to be seen as a
unsure tender to multinationals. While a country’s oil revenues
are significant, income placement stays intensely uneven, resulting
in per capita spending on medicines of underneath US$10 per annum, many of
that is met by private funding. Affordability of pharmaceuticals
has come underneath serve vigour due to a Jan 2012 dismissal of fuel
subsidies, that have resulted in aloft acceleration and increased
prolongation and logistical costs and that is expected to serve boost
prevalent counterfeiting in a country.
Headline Expenditure Projections
-Pharmaceuticals: NGN143.65bn (US$921mn) in
Category: Business
No related posts.
Subscribe
If you enjoyed this article, subscribe to receive more just like it.
